- Home
- WTM vs TERN Comparison
WTM vs TERN Comparison
Compare WTM & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTM | TERN |
|---|---|---|
| Founded | 1980 | 2017 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.8B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WTM | TERN |
|---|---|---|
| Price | $2,144.08 | $52.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $45.22 |
| AVG Volume (30 Days) | 15.7K | ★ 3.1M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | ★ 0.05% | N/A |
| EPS Growth | ★ 379.05 | 8.04 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,735,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 66.76 | N/A |
| 52 Week Low | $1,648.00 | $2.98 |
| 52 Week High | $2,333.00 | $53.19 |
Technical Indicators
Market Signals| Indicator | WTM | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 74.51 |
| Support Level | $2,025.76 | $52.42 |
| Resistance Level | $2,236.29 | $53.19 |
| Average True Range (ATR) | 53.43 | 0.07 |
| MACD | 2.84 | -0.31 |
| Stochastic Oscillator | 65.92 | 97.30 |
Price Performance
Historical ComparisonAbout WTM White Mountains Insurance Group Ltd.
White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations. The company has four reportable segments: Ark/WM Outrigger, HG Global, Kudu and Distinguished.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.